PDXモデルのアジア太平洋市場:企業概要・規模・シェア・成長・動向・予測(~2025年)

【英語タイトル】Asia-Pacific PDX Models Market : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Data Bridge Market Researchが出版した調査資料(DBMR810495)・商品コード:DBMR810495
・発行会社(調査会社):Data Bridge Market Research
・発行日:2018年7月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:アジア太平洋
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Corporate UserUSD3,200 ⇒換算¥361,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、PDXモデルのアジア太平洋市場について調査・分析し、PDXモデルのアジア太平洋市場動向、市場予測、セグメント別分析、PDXモデル市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

Asia-Pacific PDX models market is estimated to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

The key market players for Asia-Pacific PDX models market are listed below:

• Crown Bioscience Inc.
• The Jackson Laboratory
• Champion Oncology, Inc.
• Charles River
• Oncodesign
• Wuxi AppTec
• Horizon Discovery Group plc
• Pharmatest Services
• Hera Biolabs
• EPO Berlin-Buch GmbH
• Xentech
• Urolead
• Creative Animodel
• EUROPDX
• MI Bioresearch Inc
• Aragen Bioscience

The market is further segmented into:
• Type
• Tumor Type
• Application
• End User

The Asia Pacific PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.
The Asia Pacific PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
The Asia Pacific PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
The Asia Pacific PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
Based on geography, the market is segmented into:
• Japan
• China
• India
• South Korea
• Australia
• Singapore
• Thailand
• Malaysia
• Indonesia
• Philippines
• Rest of Asia Pacific
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific PDX models for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table Of Contents
1 Introduction 11
1.1 Objectives Of The Study 11
1.2 Market Definition 11
1.3 Overview Of Asia-Pacific Pdx Models Market 11
1.4 Currency And Pricing 12
1.5 Limitation 12
1.6 Markets Covered 12
2 Market Segmentation 14
2.1 Markets Covered 14
2.2 Geographic Scope 15
2.3 Years Considered For The Study 15
2.4 Currency And Pricing 16
2.5 Research Methodology 17
2.6 Primary Interviews With Key Opinion Leaders 20
2.7 Secondary Sources 21
2.8 Assumptions 21
3 Market Overview 22
3.1 Drivers 24
3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research 24
3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach 26
3.1.3 Rising Need For Personalized Medicine 27
3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization 27
3.2 Restraints 28
3.2.1 High Cost Of Pdx Models 28
3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research 28
3.3 Opprtunities 29
3.3.1 Increasing Demand For Humanized Pdx Models 29
3.4 Challenges 30
3.4.1 Limitations Of Pdx Models 30
4 Executive Summary 31
5 Premium Insights 33
6 Asia-Pacific Pdx Models Market, By Type 36
6.1 Overview 37
6.2 Mice Models 39
6.3 Rat Models 40
7 Asia-Pacific Pdx Models Market, By Tumor Type 41
7.1 Overview 42
7.2 Gastrointestinal Tumor Models 44
7.3 Gynecological Tumor Models 45
7.4 Respiratory Tumor Models 46
7.5 Urological Tumor Models 47
7.6 Hematological Tumor Models 48
7.7 Others 49
8 Asia-Pacific Pdx Models Market, By Application 50
8.1 Overview 51
8.2 Preclinical Drug Development And Oncology Research 53
8.3 Biomarker Analysis 54
9 Asia-Pacific Pdx Models Market, By End User 55
9.1 Overview 56
9.2 Contract Research Organizations 58
9.3 Pharmaceutical And Biotechnology Companies 59
9.4 Academic And Research Institutions 60
10 Asia-Pacific Pdx Models Market, By Geography 61
10.1 Asia Pacific 61
10.1.1 Japan 70
10.1.2 China 72
10.1.3 India 74
10.1.4 South Korea 76
10.1.5 Australia 78
10.1.6 Singapore 80
10.1.7 Thailand 82
10.1.8 Malaysia 84
10.1.9 Indonesia 87
10.1.10 Philippines 89
10.1.11 Rest Of Asia Pacific 91
11 Asia-Pacific Pdx Models Market, Company Landscape 92
11.1 Company Share Analysis: Asia Pacific 92
12 Company Profiles 93
12.1 Charles River 93
12.1.1 Company Overview 93
12.1.2 Revenue Analysis 93
12.1.3 Company Share Analysis 94
12.1.4 Product Portfolio 94
12.1.5 Recent Developments 94
12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation) 95
12.2.1 Company Overview 95
12.2.2 Geographic Presence 95
12.2.3 Company Share Analysis 96
12.2.4 Product Portfolio 96
12.2.5 Recent Developments 97
12.3 Champion Oncology, Inc 98
12.3.1 Company Overview 98
12.3.2 Revenue Analysis 98
12.3.3 Company Share Analysis 99
12.3.4 Product Portfolio 99
12.3.5 Recent Developments 99
12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited) 100
12.4.1 Company Overview 100
12.4.2 Product Portfolio 100
12.4.3 Recent Developments 100
12.5 Creative Animodel 101
12.5.1 Company Overview 101
12.5.2 Product Portfolio 101
12.5.3 Recent Developments 101
12.6 Epo Berlin-Buch Gmbh 102
12.6.1 Company Overview 102
12.6.2 Product Portfolio 102
12.6.3 Recent Developments 102
12.7 Europdx 103
12.7.1 Company Overview 103
12.7.2 Geographical Presence 103
12.7.3 Product Portfolio 104
12.7.4 Recent Developments 104
12.8 Hera Biolabs 105
12.8.1 Company Overview 105
12.8.2 Product Portfolio 105
12.8.3 Recent Developments 105
12.9 Horizon Discovery Group Plc 106
12.9.1 Company Overview 106
12.9.2 Revenue Analysis 106
12.9.3 Product Portfolio 107
12.9.4 Recent Developments 107
12.10 Mi Bioresearch Inc 108
12.10.1 Company Overview 108
12.10.2 Product Portfolio 108
12.10.3 Recent Developments 108
12.11 Oncodesign 109
12.11.1 Company Overview 109
12.11.2 Revenue Analysis 109
12.11.3 Product Portfolio 110
12.11.4 Recent Developments 110
12.12 Pharmatest Services Ltd 111
12.12.1 Company Overview 111
12.12.2 Geographic Presence 111
12.12.3 Product Portfolio 112
12.12.4 Recent Developments 112
12.13 The Jackson Laboratory 113
12.13.1 Company Overview 113
12.13.2 Revenue Analysis 113
12.13.3 Product Portfolio 114
12.13.4 Recent Developments 114
12.14 Urolead 115
12.14.1 Company Overview 115
12.14.2 Product Portfolio 115
12.14.3 Recent Developments 115
12.15 Wuxi Apptec 116
12.15.1 Company Overview 116
12.15.2 Geographic Presence 116
12.15.3 Product Portfolio 117
12.15.4 Recent Developments 117
12.16 Xentech 118
12.16.1 Company Overview 118
12.16.2 Product Portfolio 118
12.16.3 Recent Developments 118
13 Related Reports 119

List Of Tables
Uu
Table 1 Asia-Pacific Pdx Models Market, By Type, 2016– 2025, (Usd Million) 38
Table 2 Asia-Pacific Mice Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 39
Table 3 Asia-Pacific Rat Models In Pdx Models Market, By Region, 2016-2025, (Usd Million) 40
Table 4 Asia-Pacific Pdx Models Market, By Tumor Type, 2016– 2025 (Usd Million) 43
Table 5 Asia-Pacific Gastrointestinal Tumor Models Market, By Region, 2016-2025, (Usd Million) 44
Table 6 Asia-Pacific Gynecological Tumor Models Market, By Region, 2016-2025, (Usd Million) 45
Table 7 Asia-Pacific Respiratory Tumor Models Market, By Region, 2016-2025, (Usd Million) 46
Table 8 Asia-Pacific Urological Tumor Models Market, By Region, 2016-2025, (Usd Million) 47
Table 9 Asia-Pacific Hematological Tumor Models Market, By Region, 2016-2025, (Usd Million) 48
Table 10 Asia-Pacific Others Tumor Types In Pdx Models Market, By Region, 2016-2025, (Usd Million) 49
Table 11 Asia-Pacific Pdx Models Market, By Application, 2016– 2025 (Usd Million) 52
Table 12 Asia-Pacific Preclinical Drug Development And Oncology Research In Pdx Models Market, By Region, 2016-2025, (Usd Million) 53
Table 13 Asia-Pacific Biomarker Analysis In Pdx Models Market, By Region, 2016-2025, (Usd Million) 54
Table 14 Asia-Pacific Pdx Models Market, By End User, 2016– 2025, (Usd Million) 57
Table 15 Asia-Pacific Contract Research Organizations In Pdx Model Market, By Region, 2016-2025, (Usd Million) 58
Table 16 Asia-Pacific Pharmaceutical And Biotechnology Companies In Pdx Models Market, By Region, 2016-2025, (Usd Million) 59
Table 17 Asia-Pacific Academic And Research Institutions In Pdx Modela Market, By Region, 2016-2025, (Usd Million) 60
Table 18 Asia Pacific Pdx Models Market, By Country , 2016 – 2025, (Usd Million) 67
Table 19 Asia Pacific Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 68
Table 20 Asia Pacific Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 68
Table 21 Asia Pacific Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 69
Table 22 Asia Pacific Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 69
Table 23 Japan Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 70
Table 24 Japan Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 70
Table 25 Japan Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 71
Table 26 Japan Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 71
Table 27 China Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 72
Table 28 China Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 72
Table 29 China Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 73
Table 30 China Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 73
Table 31 India Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 74
Table 32 India Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 74
Table 33 India Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 75
Table 34 India Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 75
Table 35 South Korea Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 76
Table 36 South Korea Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 76
Table 37 South Korea Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 77
Table 38 South Korea Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 77
Table 39 Australia Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 78
Table 40 Australia Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 78
Table 41 Australia Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 79
Table 42 Australia Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 79
Table 43 Singapore Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 80
Table 44 Singapore Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 80
Table 45 Singapore Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 81
Table 46 Singapore Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 81
Table 47 Thailand Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 82
Table 48 Thailand Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 82
Table 49 Thailand Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 83
Table 50 Thailand Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 83
Table 51 Malaysia Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 84
Table 52 Malaysia Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 85
Table 53 Malaysia Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 85
Table 54 Malaysia Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 86
Table 55 Indonesia Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 87
Table 56 Indonesia Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 87
Table 57 Indonesia Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 88
Table 58 Indonesia Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 88
Table 59 Philippines Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 89
Table 60 Philippines Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million) 89
Table 61 Philippines Pdx Models Market, By Application, 2016 – 2025, (Usd Million) 90
Table 62 Philippines Pdx Models Market, By End User, 2016 – 2025, (Usd Million) 90
Table 63 Rest Of Asia Pacific Pdx Models Market, By Type, 2016 – 2025, (Usd Million) 91




【レポートのキーワード】

PDXモデル

★調査レポート[PDXモデルのアジア太平洋市場:企業概要・規模・シェア・成長・動向・予測(~2025年)] (コード:DBMR810495)販売に関する免責事項を必ずご確認ください。
★調査レポート[PDXモデルのアジア太平洋市場:企業概要・規模・シェア・成長・動向・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆